⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

Lemborexant Treatment in Older Adults with Insomnia and Objective Short Sleep: Rates of Response and Remission (P8-9.015)

Jack D. Edinger Andrew D. Krystal Dinesh Kumar Margaret Moline

View Full Paper

Ask AI

Bookmark

Share

Abstract

To examine response and remission rates, defined using the Insomnia Severity Index (ISI), with lemborexant (LEM) in older adults with insomnia disorder and objective short sleep (I-SSD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Edinger et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677f0b https://doi.org/10.1212/wnl.0000000000205300

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder2024 · 18 citations
2Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials2024 · 14 citations
3A plain language summary: an overview of objective (scientific) data and patient experiences showing how effective lemborexant is for treating insomniaOriginal Research · 2026
4Assessing the Real-World, Long-Term Impact of Lemborexant on Sleep Quality in a Home-Based Clinical Study2024 · 12 citations
5Patient-Reported Outcomes for LEMborexant Treatment in Chinese Patients with Insomnia (PROEM): A Multicenter, Prospective, Real-World Observational StudyObservational Study · 2026